Notice names this product. Wisconsin Pharmacal Company’s MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) is named in FDA Class I recall D-0553-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus. Identifying details: Lot #: 1024088, Exp 11/30/2026. Units affected: 690 tubes. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Company / brand: Wisconsin Pharmacal Company recalls
Affected product: MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) recall status
Official ID D-0553-2026 · Official record ↗
See all Wisconsin Pharmacal Company recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked September 20, 2026 at 6:00 PM UTC.